Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF -Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial.
Paolo Antonio AsciertoMario MandalaPier Francesco FerrucciMassimo GuidoboniPiotr Lukasz RutkowskiVirginia FerraresiAna M AranceMichele GuidaEvaristo MaielloHelen J GogasErika RichtigMaria Teresa FierroCeleste LebbèHildur HelgadottirPaola QueiroloFrancesco SpagnoloMarco TucciMichele Del VecchioMaria Gonzales CaoAlessandro Marco MinisiniSabino De PlacidoMiguel F SanmamedDomenico MallardoMarcello CurviettoIgnacio MeleroGiuseppe PalmieriAntonio M GrimaldiDiana GiannarelliReinhard DummerVanna Chiarion SileniPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
-mutant melanoma.